Search results
Results From The WOW.Com Content Network
Big Pharma: The government revealed its list of negotiated drug prices. ... predicted a $100 billion savings over 10 years from drug negotiations, and a $3.7 billion savings in the first year ...
The Liusons, a traditional Chinese family has been involved in the pharmaceutical industry since 1959 through Pacific Pharma, an importer and wholesaler of drugs. [3] In 1983, Pacific Pharma shifted to investing on generic drugs. [3] The company initially largely sold generic drugs wholesale to government hospitals. [4]
This list is based on the Forbes Global 2000, which ranks the world's 2,000 largest publicly traded companies.The Forbes list takes into account a multitude of factors, including the revenue, net profit, total assets and market value of each company; each factor is given a weighted rank in terms of importance when considering the overall ranking.
Two types of insulin, both manufactured by Eli Lilly , are among the top 10 drugs with the biggest price increases. Humulin saw the biggest price hike, rising 1,070.1% from $67 in 2012 to $1,512 ...
The Federal Trade Commission had its first win earlier this week in its crusade to block drug company deals: Sanofi on Monday ended its up-to-$735 million licensing deal with Maze Therapeutics.
AstraZeneca claimed the deal undervalued the company. [15] 4 2014 Pfizer: Astra Zeneca: 99 127 AstraZeneca claimed the deal undervalued the company. [16] 5 1999 Pfizer: Warner–Lambert: 82.4 151 Pfizer made a hostile bid, just after the announcement of a $72 billion deal with Wyeth, the eventual purchase price would be in excess of $90 billion ...
When drugs have no competition, the law allows the government to negotiate prices for complex biologic, or biotech, drugs after 13 years on the market, but after 9 years for drugs taken as pills ...
The following list sorts countries by the total market capitalization of all domestic companies [clarification needed] listed in the country, according to data from the World Bank. Market capitalization, commonly called market cap, is the market value of a publicly traded company's outstanding shares. [1]